In humans, haploinsufficiency of GATA2 caused by heterozygous spontaneous or autosomal dominant mutations causes a wide spectrum of clinical implications ranging from lymphedema, predisposition to mycobacterial, and viral infections to bone marrow failure with MDS/AML. Here, GATA2 is linked to Bone marrow hypocellularity.